Pain Therapeutics, Inc. (NASDAQ:PTIE)
| CAPS Rating |
|
|---|---|
| Open | $4.09 |
| Previous Close | $4.12 |
| Daily Range | $4.02 - $4.23 |
| 52-Week Range | $3.28 - $10.45 |
| Market Cap | $180.75M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 70,879 |
| Average Daily Volume | 0 |
PTIE
VS S&P 500 (SPY)
How do you think PTIE will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PTIE Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PTIE News and Commentary
- Market Correlation: From Record Highs to the Lowest in 25 Years – The Motley Fool
- Durect Investors Feel the Pain – The Motley Fool
- Wall Street's Wrong About These Stocks – The Motley Fool
- 3 Stocks Stopping the Presses – The Motley Fool
- A Less Painful FDA Decision – The Motley Fool
- Like It (Almost) Never Happened – The Motley Fool
- 3 Top Stocks at Half-Price – The Motley Fool
- 5 of Last Week's Biggest Losers – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Double Ouch! 2 Monster Drops in 2 Trading Days – The Motley Fool
- Pain Therapeutics Shares Plunged: What You Need to Know – The Motley Fool
- 5 of Last Week's Biggest Losers – The Motley Fool
- Pain Therapeutics: FDA Says Pain Killer Had Inconsistent Results – SmartMoney
- Stock Futures Drift Higher as Traders Eye Greek Developments – Fox Business
- Come On, Pfizer, Not Even a Little Hint? – The Motley Fool
- Pain Therapeutics Shares Plunged: What You Need to Know – The Motley Fool
- Stocks Slump, But Off Lows, as Investors Eye Revised GDP Data; Commodities in Red – NASDAQ
- Mid-Day Update: Stocks Lower; Earnings, GDP Data Disappoint – NASDAQ
- Pain Therapeutics, Durect Shares Plunge on Pain Drug Rejection – Minyanville
RSS Headlines
Fool UK
